Evidence map›Paper›PMID 34777352›Full record

ArticleFrontiers in immunology2021

Polymorphisms of the

Anna S Świerzko, Dariusz Jarych, Gabriela Gajek, Karolina Chojnacka, Paulina Kobiela, Maja Kufelnicka-Babout, Mateusz Michalski, Katarzyna Sobczuk, Agnieszka Szala-Poździej, Misao Matsushita and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Association of theInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Anna S ŚwierzkoLaboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Dariusz JarychLaboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Gabriela GajekLaboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Karolina ChojnackaDepartment of Newborns' Infectious Diseases, Poznań University of Medical Sciences, Poznań, Poland.
Paulina KobielaDepartment of Neonatology, Medical University of Gdańsk, Gdańsk, Poland.
Maja Kufelnicka-BaboutDepartment of Perinatology, First Chair of Gynecology and Obstetrics, Medical University of Łódź, Łódź, Poland.
Mateusz MichalskiLaboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Katarzyna SobczukDepartment of Perinatology, First Chair of Gynecology and Obstetrics, Medical University of Łódź, Łódź, Poland.
Agnieszka Szala-PoździejLaboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Misao MatsushitaDepartment of Applied Biochemistry, Tokai University, Hiratsuka, Japan.
Jan MazelaDepartment of Newborns' Infectious Diseases, Poznań University of Medical Sciences, Poznań, Poland.
Iwona Domżalska-PopadiukDepartment of Neonatology, Medical University of Gdańsk, Gdańsk, Poland.
David C KilpatrickScottish National Blood Transfusion Service, National Science Laboratory, Edinburgh, Scotland, United Kingdom.
Jarosław KalinkaDepartment of Perinatology, First Chair of Gynecology and Obstetrics, Medical University of Łódź, Łódź, Poland.
Hideharu SekineDepartment of Immunology, Fukushima Medical University, Fukushima, Japan.
Maciej CedzyńskiLaboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Polish Academy of Sciences · PLMedical University of Lodz · PLGdańsk Medical University · PLPoznan University of Medical Sciences · PLFukushima Medical University · JPScottish National Blood Transfusion Service · GBTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ficolin-2 is regarded as an important innate immunity factor endowed with both lectin (carbohydrate recognition) qualities and ability to induce complement activation. The aim of this study was to investigate the association of the

Indexed as

GenotypeInfant, Premature3' Untranslated RegionsComplement ActivationFemaleFicolinsGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHumansImmunity, InnateInfant, NewbornInfectionsLectinsLinkage DisequilibriumMale3' Untranslated RegionsFicolinsLectins3’UTRFCN2ficolin-2newbornprematurity

Identifiers

PMID34777352
PMCPMC8581395
OpenAlexW3208210665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.